|
FY2025
12 months to Dec 26, 2025
|
FY2024
12 months to Dec 27, 2024
|
FY2023
12 months to Dec 29, 2023
|
FY2022
12 months to Dec 30, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities | |||||
| Net Earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Gain on sale of building | |||||
| Share-based compensation | |||||
| Pension settlement loss | |||||
| Contingent consideration | |||||
| Impairment | |||||
| Change in | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Trade accounts payable | |||||
| Salaries and incentives | |||||
| Retirement benefits and deferred compensation | |||||
| Other accrued liabilities | |||||
| Other | |||||
| Net cash provided by operating activities | |||||
| Cash Flows From Investing Activities | |||||
| Property, plant and equipment additions | |||||
| Proceeds from sale of building | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash Flows From Financing Activities | |||||
| (Payments) borrowings on short-term lines of credit, net | |||||
| (Payments) borrowings on short-term lines of credit, net | |||||
| Payments of debt issuance costs | |||||
| Common stock issued | |||||
| Common stock repurchased | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Cash dividends paid | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and Cash Equivalents | |||||
| Beginning of year | |||||
| End of year | |||||
Loading...